Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes

Desalination

Volumn 261, Issue 1-2, 2010, Pages 148-156

  Tambosi, José Luiz ^a,b   de Sena, Rênnio Felix ^a,b   Favier, Maxime ^b   Gebhardt, Wilhelm ^b   José, Humberto Jorge ^a   Schröder, Horst Friedrich ^b   de Fatima Peralta Muniz Moreira, Regina ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Elimination; Mass spectrometry (MS); Membrane bioreactor (MBR); Pharmaceuticals; Wastewater

Indexed keywords

ACTIVATED SLUDGE PROCESS; ANTIBIOTICS; AQUATIC ORGANISMS; BIOCONVERSION; BIOLOGICAL WATER TREATMENT; BIOREACTORS; DRUG PRODUCTS; EFFICIENCY; FILTRATION; GROUNDWATER; MASS SPECTROMETRY; POTABLE WATER; RISK ASSESSMENT; SEWAGE TREATMENT PLANTS; SURFACE TREATMENT; SURFACE WATERS; WASTEWATER; WASTEWATER TREATMENT; WATER FILTRATION; WATER TREATMENT;

BIOLOGICAL TRANSFORMATION; ELIMINATION; MEMBRANE BIO REACTOR (MBR); NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHARMACEUTICAL COMPOUNDS; SURFACE AND GROUND WATERS; TRANSFORMATION PRODUCTS; WASTEWATER TREATMENT TECHNOLOGIES;

EFFLUENTS;

ANTIBIOTICS; BIOREACTOR; CHEMICAL COMPOUND; DRUG; ENVIRONMENTAL RISK; MASS SPECTROMETRY; MEMBRANE; RETENTION; WASTEWATER;

EID: 78049432254     PISSN: 00119164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.desal.2010.05.014     Document Type: Article

References (45)

1. K. Kimura, H. Hara, Y. Watanabe, Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs), Desalination 178 (2005) 135-140.
2. A.M. Comerton, R.C. Andrews, D.M. Bagley, P. Yang, Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds, J. Membr. Sci. 303 (2007) 267-277.
3. W. Gebhardt, H.Fr. Schröder, Liquid chromatography-(tandem) mass spectrometry for the follow-up of the elimination of persistent pharmaceuticals during wastewater treatment applying biological wastewater treatment and advanced oxidation, J. Chromatogr. A 1160 (2007) 34-43.
4. A. Göbel, C.S. McArdell, A. Joss, H. Siegrist, W. Giger, Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies, Sci. Total Environ. 372 (2007) 361-371.
5. R. Andreozzi, R. Marotta, N. Paxéus, Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere 50 (2003) 1319-1330.
6. M. Stumpf, T.A. Ternes, R.D. Wilken, S.V. Rodrigues, W. Baumann, Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil, Sci. Total Environ. 225 (1999) 135-141.
7. M. Favier, R.F. Sena, H.J. José, U. Bieling, H. Fr. Schröder, Liquid chromatographytandem mass spectrometry for the screening of pharmaceuticals and metabolites in various water bodies in Florianópolis, Santa Catarina, Brazil. Proceedings Ecosan-Fortaleza, Conference; 26.-28.11.2007 in Fortaleza, Ceará, Brazil.
8. T.A. Ternes, M. Stumpf, J. Mueller, K. Haberer, R.D. Wilken, M. Servos, Behavior and occurrence of estrogens in municipal sewage treatment plants-I. Investigations in Germany, Canada and Brazil, Sci. Total Environ. 225 (1999) 81-90.
9. X.S. Miao, F. Bishay, M. Chen, C.D. Metcalfe, Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada, Environ. Sci. Technol. 38 (2004) 3533-3541.
10. A. Gulkowska, H.W. Leung, M.K. So, S. Taniyasu, N. Yamashita, L.W.Y. Yeung, B.J. Richardson, A.P. Lei, J.P. Giesy, P.K.S. Lam, Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China, Water Res. 42 (2008) 395-403.
11. W. Xu, G. Zhang, X. Li, S. Zou, P. Li, Z. Hu, J. Li, Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China, Water Res. 41 (2007) 4526-4534.
12. T.A. Ternes, Occurrence of drugs in German sewage treatment plants and rivers, Water Res. 32 (1998) 3245-3260.
13. K. Kümmerer, Drugs in environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review, Chemosphere 45 (2001) 957-969.
14. S. Castiglioni, R. Fanelli, D. Calamari, R. Bagnati, E. Zuccato, Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy, Regul. Toxicol. Pharmacol. 39 (2004) 25-32.
15. M. Carballa, F. Omil, J.M. Lema, Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment, Water Res. 39 (2005) 4790-4796.
16. J.L. Santos, I. Apacicio, E. Alonso, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city, Environ. Int. 33 (2007) 596-601 (Spain).
17. A. Tauxe-Wuersch, L.F. De Alencastro, D. Grandjean, J. Tarradellas, Occurrence of several acidic grugs in sewage treatment plants in Switzerland and risk assessment, Water Res. 39 (2005) 1761-1772.
18. K. Fent, A.A. Weston, D. Caminada, Ecotoxicology of human pharmaceuticals, Aquat. Toxicol. 76 (2006) 122-159.
19. K.D. Brown, J. Kulis, B. Thomson, T.H. Chapman, D.B. Mawhinney, Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico, Sci. Total Environ. 366 (2006) 772-783.
20. K.G. Karthikeyan, M.T. Meyer, Occurrence of antibiotics in wastewater treatment facilities in Wisconin, USA, Sci. Total Environ. 371 (2006) 196-207.
21. T. Takagi, C. Ramachandran, M. Bermejo, S. Yamashita, L. YU, G. Amidon, A provisional biopharmaceutical classification of the top 200 drug products in the United States, Great Britain, Spain and Japan, Mol. Pharm. 3 (2006) 631-643.
22. S. Gartiser, E. Urich, R. Alexy, K. Kümmerer, Ultimate biodegradation and elimination of antibiotics in inherent tests, Chemosphere 67 (2007) 604-613.
23. R. Molinari, F. Pirillo, V. Loddo, L. Palmisano, Heterogeneous photocatalytic degradation of pharmaceuticals in water by using polycrystalline TiO2 and a nanofiltration membrane reactor, Catal. Today 118 (2006) 205-213.
24. B. Halling-Sørensen, S.N. Nielsen, P.F. Lanzky, F. Ingerslev, H.C.H. Lützhøft, S.E. Jørgensen, Occurrence, fate and effects of pharmaceutical substances in the environment-a review, Chemosphere 36 (1998) 357-394.
25. J.P. Sumpter, Xenoendocrine disrupters - environmental impacts, Toxicol. Lett. 102 (1998) 337-342.
26. K. Kümmerer, Resistance in the environment, J. Antimicrob. Chemother. 54 (2004) 311-320.
27. P.E. Stackelberg, E.T. Furlong, M.T. Meyer, S.D. Zaugg, A.K. Henderson, D.B. Reissman, Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant, Sci. Total Environ. 329 (2004) 99-113.
28. N. Vieno, T. Tuhkanen, L. Kronberg, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res. 41 (2007) 1001-1012.
29. P. Le-Clech, V. Chen, T.A.G. Fane, Fouling in membrane bioreactors used in wastewater treatment, J. Membr. Sci. 284 (2006) 17-53.
30. H.Fr. Schröder, Mass spectrometric monitoring of the degradation and elimination efficiency for hardly eliminable and hardly biodegradable, polar compounds by membrane bioreactors, Water Sci. Technol. 46 (2002) 57-64.
31. O.A.H. Jones, N. Voulvoulis, J.N. Lester, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals, Water Res. 36 (2002) 5013-5022.
32. S.J. Khan, J.E. Ongerth, Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations, Chemosphere 54 (2004) 335-367.
33. J.B. Quintana, S. Weiss, T. Reemtsma, Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor, Water Res. 39 (2005) 2654-2664.
34. T. Urase, T. Kikuta, Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process, Water Res. 39 (2005) 1289-1300.
35. T.A. Ternes, M. Bonerz, N. Hermann, B. Teiser, H.R. Andersen, Irrigation of treated wastewater in Braunschweig Germany: an option to remove pharmaceuticals and musk fragrances, Chemosphere 66 (2007) 894-904.
36. H.S. Fogler, Elements of Chemical Reaction Engineering, Prentice Hall, Englewood Cliffs, New Jersey, 1992.
37. B. Testa, S.D. Krämer, The biochemistry of drug metabolism - an introduction: Part 3. Reactions of hydrolysis and their enzymes, Chem. Biodivers. 4 (2007) 2031-2122.
38. B. Testa, S.D. Krämer, The biochemistry of drug metabolism - an introduction: Part 4. Reactions of conjugation and their enzymes, Chem. Biodivers. 5 (2008) 2171-2336.
39. H.Fr. Schröder, Tracing of surfactants in the biological wastewater treatment process and the identification of their metabolites by flow injection-mass spectrometry and liquid chromatography-mass spectrometry and tandem mass spectrometry, J. Chromatogr. A 926 (2001) 127-150.
40. S.D. Kim, J. Cho, I.S. Kim, B.J. Vanderford, S.A. Snyder, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters, Water Res. 41 (2007) 1013-1021.
41. P.M. Thomas, G.D. Foster, Determination of non-steroidal anti-inflammatory drugs, caffeine, and triclosan in wastewater by gas chromatography-mass spectrometry, J. Environ. Sci. Health A 39 (2004) 1969-1978.
42. N. Nakada, T. Tanishima, H. Shinohara, K. Kiri, H. Takada, Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment, Water Res. 40 (2006) 3297-3303.
43. N. Lindqvist, T. Tuhkanen, L. Kronberg, Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters, Water Res. 39 (2005) 2219-2228.
44. C.D. Metcalfe, B.G. Koenig, D.T. Bennie, M. Servos, T.A. Ternes, R. Hirsch, Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants, Environ. Toxicol. Chem. 22 (2003) 2872-2880.
45. M. Carballa, F. Omil, J.M. Lema, M. Llompart, C. García-Jares, I. Rodríguez, M. Gómez, T. Ternes, Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Res. 38 (2004) 2918-2926.